Flavone derivative and preparation method and medical application of flavone derivative
A technology of derivatives and flavones, which is applied in the field of flavone derivatives and their preparation, to achieve the effect of easy-to-obtain raw materials, high yield, and fewer steps
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0070] The flavone derivatives provided by the present invention or their pharmaceutically acceptable salts have the following structure:
[0071]
[0072] in:
[0073] (1) R1 is independently selected from the following substituent groups: H, C1-C6 alkyl;
[0074] (2) R2 is independently selected from the following substituent groups: H, C1-C6 alkyl, C3-C8 cycloalkyl, C2-C6 alkenyl, C2-C6 fatty acyl, C7-C12 aroyl;
[0075] (3) R3 is independently selected from the following substituent groups: H, C1-C6 alkyl.
[0076] Further, the flavone derivatives provided by the present invention or pharmaceutically acceptable salts thereof are preferably R1=H, R2=C2-C6 alkenyl, R3=CH3.
Embodiment 2
[0078] The flavone derivatives provided by the present invention or their pharmaceutically acceptable salts are code-named YS10 and have the following structure:
[0079]
[0080] The synthesis of flavone derivative YS10 comprises the following steps:
[0081] (1) Mix 6g (16.3mmol) dehydrated icariin with 80mL DMF, add 3.38g (24.5mmol) anhydrous potassium carbonate to it, stir for 10 minutes and slowly add 1.97mL (19.6mmol) 3- Bromo-2-methylpropene, after addition, react at room temperature.
[0082] (2) TLC (petroleum ether: dichloromethane: methanol = 40:40:1) followed the reaction, and the reaction was complete after about 8 hours. After the reaction was completed, pour the reaction solution into 500 mL of ice water, stir and let stand for one hour, a large amount of light yellow solid precipitated, filtered with suction, washed the filter cake with water three times and dried to obtain the crude product of YS-10. Pass the crude product through a silica gel column (pet...
Embodiment 3
[0098] Use of the flavone derivative YS10 in a drug for preventing or treating erectile dysfunction.
[0099] The first part, in vitro experiment: the comparison of flavone derivative YS10 and dehydrated icariin on the activation of adipose stem cells.
[0100] Research Background:
[0101] Chronic diseases that endanger human health include complications caused by common diseases such as diabetes, hypertension, obesity, trauma, etc., which mainly occur in important parenchymal organs such as heart, brain, kidney, and genital tissues, blood vessels, nerves, and matrix. Death, degeneration, necrosis, and degenerative pathological changes cause related organ dysfunction. Therefore, exploring the pathophysiological mechanism of tissue damage repair and exploring drugs and methods that can prevent and treat these pathophysiological changes are currently major challenges to maintaining organ function, and this patent invention is based on this.
[0102] This study takes erectile ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com